Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
The preliminary content is calculated using a standard curve, allowing rapid screening of whether the preparation meets basic quality requirements
Proper implementation of these research protocols requires careful attention to dosage precision, safety monitoring, and data collection methodologies
INDICATIONS: For vitamin B12 deficiency caused by megaloblastic anemia, multiple neuritis, neuralgia, growth retardation and other young animals
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
